Molecular Devices to Enlarge Sales, Service Operations in Asia, South America This Year | GenomeWeb

Molecular Devices is planning to open new offices in China and India and intends to expand its South American operations this year, CEO Joe Keegan told BioCommerce Week.

Keegan also said the company will continue to follow its past strategy of making one small acquisition per year, and cautioned that as Molecular Devices itself matures into an attractive acquisition target, the company would not come cheap.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.